Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $383.5900 (0.26%) ($383.5900 - $383.5900) on Thu. Jan. 9, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.54% (three month average) | RSI | 67 | Latest Price | $383.5900(0.26%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.6% a day on average for past five trading days. | Weekly Trend | REGN advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(48%) IVW(41%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -0.77% in a week (0% probabilities). VIXM(-23%) VXX(-10%) TLT(-6%) TIP(-1%) UUP(2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.77% (StdDev 1.54%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $376.06(2%) | 10 Day Moving Average | $375.23(2.23%) | 20 Day Moving Average | $374.52(2.42%) | To recent high | 0% | To recent low | 31.9% | Market Cap | $40.672b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |